These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 1327673)
1. [Detection of hepatitis B virus DNA in leucocytes of primary hepatocarcinoma using polymerase chain reaction]. Wang BC; Li Z; Yang DL Zhonghua Nei Ke Za Zhi; 1992 Feb; 31(2):90-2, 126. PubMed ID: 1327673 [TBL] [Abstract][Full Text] [Related]
2. Molecular and serological aspects of HBsAg-negative hepatitis B virus infections in North America. Hsia CC; Scudamore CH; Di Bisceglie AM; Tabor E J Med Virol; 2003 May; 70(1):20-6. PubMed ID: 12629639 [TBL] [Abstract][Full Text] [Related]
3. Real-time quantitation of hepatitis B virus (HBV) DNA in tumorous and surrounding tissue from patients with hepatocellular carcinoma. Zanella I; Rossini A; Domenighini D; Albertini A; Cariani E J Med Virol; 2002 Dec; 68(4):494-9. PubMed ID: 12376956 [TBL] [Abstract][Full Text] [Related]
4. Detection of HBV DNA in non-A, non-B hepatic tissues using the polymerase chain reaction assay. Ohkoshi S Gastroenterol Jpn; 1991 Dec; 26(6):728-33. PubMed ID: 1662652 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus, alcoholic cirrhosis, and hepatocellular carcinoma. Goeser T; Müller HM; Solbach C; Toex U; Kommerell B; Theilmann L Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):311-5. PubMed ID: 8061579 [TBL] [Abstract][Full Text] [Related]
6. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma. Momosaki S; Nakashima Y; Kojiro M; Tabor E J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475 [TBL] [Abstract][Full Text] [Related]
7. The detection of hepatitis B virus (HBV) in HBsAG negative individuals with primary liver cancer. Paterlini P; Bréchot C Dig Dis Sci; 1991 Aug; 36(8):1122-9. PubMed ID: 1650688 [TBL] [Abstract][Full Text] [Related]
8. Virological significance of low-level hepatitis B virus infection in patients with hepatitis C virus associated liver disease. Tanaka T; Inoue K; Hayashi Y; Abe A; Tsukiyama-Kohara K; Nuriya H; Aoki Y; Kawaguchi R; Kubota K; Yoshiba M; Koike M; Tanaka S; Kohara M J Med Virol; 2004 Feb; 72(2):223-9. PubMed ID: 14695663 [TBL] [Abstract][Full Text] [Related]
9. [Identification of latent HBV infection in primary hepatic carcinoma and liver cirrhosis with polymerase chain reaction]. Yang JM; Liu WW Zhonghua Nei Ke Za Zhi; 1993 Mar; 32(3):152-4. PubMed ID: 8222976 [TBL] [Abstract][Full Text] [Related]
10. [Nested polymerase chain reaction (PCR) and multiple cloned antibody capture PCR for the examination of serum hepatitis B virus DNA in negative hepatitis B surface antigen patients suffering from liver diseases]. He J; Wu J; Du S Zhonghua Nei Ke Za Zhi; 1996 Aug; 35(8):537-41. PubMed ID: 9594146 [TBL] [Abstract][Full Text] [Related]
11. Quantification of hepatitis B virus DNA over a wide range from serum for studying viral replicative activity in response to treatment and in recurrent infection. Ranki M; Schätzl HM; Zachoval R; Uusi-Oukari M; Lehtovaara P Hepatology; 1995 Jun; 21(6):1492-9. PubMed ID: 7768492 [TBL] [Abstract][Full Text] [Related]
12. Occult hepatitis B viral DNA in liver carcinomas from a region with a low prevalence of chronic hepatitis B infection. Kannangai R; Molmenti E; Arrazola L; Klein A; Choti M; Thomas DL; Torbenson M J Viral Hepat; 2004 Jul; 11(4):297-301. PubMed ID: 15230851 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis C and B virus infections in hepatocellular carcinoma. Analysis of direct detection of viral genome in paraffin embedded tissues. Edamoto Y; Tani M; Kurata T; Abe K Cancer; 1996 May; 77(9):1787-91. PubMed ID: 8646675 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of occult hepatitis B virus infection among hepatopathy patients and healthy people in China. Fang Y; Shang QL; Liu JY; Li D; Xu WZ; Teng X; Zhao HW; Fu LJ; Zhang FM; Gu HX J Infect; 2009 May; 58(5):383-8. PubMed ID: 19329189 [TBL] [Abstract][Full Text] [Related]
15. [Hepatita B and C virus infections in patients with hepatocellular carcinoma]. Crespo J; Dueñas C; Sánchez-Antolín G; Fábrega E; Carte B; Pons-Romero F Med Clin (Barc); 1996 Feb; 106(7):241-5. PubMed ID: 8667672 [TBL] [Abstract][Full Text] [Related]
16. [Serum anti-hepatitis C virus and hepatitis C virus RNA in patients with hepatocellular carcinoma]. Jiang MD Zhonghua Yi Xue Za Zhi; 1993 Mar; 73(3):131-4, 189. PubMed ID: 7686810 [TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus. Tamori A; Nishiguchi S; Shiomi S; Hayashi T; Kobayashi S; Habu D; Takeda T; Seki S; Hirohashi K; Tanaka H; Kubo S Am J Gastroenterol; 2005 Aug; 100(8):1748-53. PubMed ID: 16086711 [TBL] [Abstract][Full Text] [Related]
18. Integrated state of subgenomic fragments of hepatitis B virus DNA in hepatocellular carcinoma from mainland China. Zhou YZ; Butel JS; Li PJ; Finegold MJ; Melnick JL J Natl Cancer Inst; 1987 Aug; 79(2):223-31. PubMed ID: 3037150 [TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus DNA in liver, serum, and peripheral blood mononuclear cells after the clearance of serum hepatitis B virus surface antigen. Murakami Y; Minami M; Daimon Y; Okanoue T J Med Virol; 2004 Feb; 72(2):203-14. PubMed ID: 14695661 [TBL] [Abstract][Full Text] [Related]
20. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan. Tamori A; Nishiguchi S; Kubo S; Narimatsu T; Habu D; Takeda T; Hirohashi K; Shiomi S J Med Virol; 2003 Dec; 71(4):492-8. PubMed ID: 14556260 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]